


The Investment Objective of the Ecclesiastical International Growth Fund is to achieve long-term capital growth with a reasonable level of income.
| Name | % Net Assets |
|---|---|
| Lonking Holdings | 2.9% |
| Telefonica S.A. ADS | 2.4% |
| Roche Holding AG Part. Cert. | 2.4% |
| StatoilHydro ASA | 2.3% |
| China Shineway Pharmaceutical Group | 2.3% |
| Sanofi-Aventis S.A. | 2.1% |
| Scud Group | 2.1% |
| GlaxoSmithKline | 2.0% |
| Swatch Group AG | 1.9% |
| Novartis | 1.7% |
| Key | % Net Assets |
|---|---|
| 2.9% | |
| 2.4% | |
| 2.4% | |
| 2.3% | |
| 90% |
| Date | 20-Jun-2025 |
|---|---|
| NAV | 429.90p |
| Currency | GBP |
| Change | -0.80p |
| % | -0.19% |
| YTD change | -10.50p |
| YTD % | -2.38% |
| Fund Inception | 13/09/1999 |
|---|---|
| Fund Manager | Robin Hepworth |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £1000000 |
| Additional | n/a |
| Savings | £25 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.15 |
You are here: research